Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_assertion type Assertion NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_head.
- NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_assertion description "[The results of this study allow us to conclude that low expression of MLH1 is associated with BRAF V600E mutations, RET/PTC rearrangements and transitions (IDH1 and NRAS) in patients with thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_provenance.
- NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_assertion evidence source_evidence_literature NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_provenance.
- NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_assertion SIO_000772 23414134 NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_provenance.
- NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_assertion wasDerivedFrom befree-2016 NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_provenance.
- NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_assertion wasGeneratedBy ECO_0000203 NP1053377.RA3GhN2PO4gsMf56fPLtgy49FO1oEy-ltsk_WqGaz-taw130_provenance.